May 10, 2022 / 05:40PM GMT
Alec Warren Stranahan - BofA Securities, Research Division - Associate
Everyone, welcome to day 1 of the 2022 Bank of America Healthcare Conference, and thank you for joining this session with NextCure. My name is Alec Stranahan. I'm Vice President and senior biotech analysts covering NextCure at BofA. It's my pleasure to be joined by Michael Richman, President and CEO of NextCure. And I believe Michael is going to run through some slides upfront to get started, and then we'll go into Q&A after that.
So with that, Michael, over to you.
Michael S. Richman - NextCure, Inc. - Co-Founder, CEO, President & Director
Thank you very much, Alec, and it's a real pleasure to be here. I'd like to thank BofA for the opportunity to present NextCure.
NextCure is a company in Beltsville, Maryland. We're celebrating a little over 6 years at really building a fully-integrated organization focused on next-generation immunomedicines is our forward-looking statement.
I always like to start with this slide. This is our 3 Ps where really sets the
NextCure Inc at Bank of America Healthcare Conference Transcript
May 10, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers